![Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile](https://pbs.twimg.com/profile_images/1207683991958110210/JrtMlwSD_200x200.png)
Journal for ImmunoTherapy of Cancer
@jitcancer
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Editor-in-Chief: Michael T. Lotze, MD
ID: 1150769339466952705
https://jitc.bmj.com/ 15-07-2019 14:09:25
5,5K Tweet
8,8K Followers
1,1K Following
![Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1207683991958110210/JrtMlwSD_200x200.png)
New #JITC review: Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018–2022 bit.ly/3AWqiy8 Colm Mac Eochagain Dr Mukul Roy Nicolò Battisti, MD
![Journal for ImmunoTherapy of Cancer (@jitcancer) on Twitter photo New #JITC review: Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018–2022 bit.ly/3AWqiy8 <a href="/CEochagain/">Colm Mac Eochagain</a> <a href="/CancerhealingDr/">Dr Mukul Roy</a> <a href="/nicolobattisti/">Nicolò Battisti, MD</a> New #JITC review: Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018–2022 bit.ly/3AWqiy8 <a href="/CEochagain/">Colm Mac Eochagain</a> <a href="/CancerhealingDr/">Dr Mukul Roy</a> <a href="/nicolobattisti/">Nicolò Battisti, MD</a>](https://pbs.twimg.com/media/GWjcPXoWcAAeC5q.jpg)